Patents Assigned to Vela Acquisition Corporation
  • Pharmaceutical composition of 1-(3,4-dimethoxyphenyl)-4-methyl-5-ethyl-7-methoxy-8-hydroxy-5H-2,3-benzodiazepine and uses thereof
    Patent number: 7745431
    Abstract: Pharmaceutical compositions comprising 1-(3,4-dimethoxyphenyl)-4-methyl-5-ethyl-7-methoxy-8-hydroxy-5H-2,3-benzodiazepine; or a pharmaceutically acceptable salt thereof. The compositions are used for treating, preventing or delaying the onset of disorders mediated by LTB4, TXA2 or adenosine.
    Type: Grant
    Filed: December 3, 2003
    Date of Patent: June 29, 2010
    Assignee: Vela Acquisition Corporation
    Inventors: Herbert W. Harris, Robert F. Kucharik, Steven M. Leventer
  • Conversion process for 2,3-benzodiazepine enantiomers
    Patent number: 7541355
    Abstract: Methods for the racemization of an enantiomer of a 2,3-benzodiazepine molecule into the corresponding racemic mixture under either basic or acidic conditions are described. Furthermore, the invention relates to the conversion of an enantiomer of tofisopam or its metabolites to the corresponding opposite enantiomer.
    Type: Grant
    Filed: May 23, 2005
    Date of Patent: June 2, 2009
    Assignee: Vela Acquisition Corporation
    Inventors: Yong Victoria Wei, Naidaong Ye, Kimm Galbraith, Jianfeng Shi, Wuyi Wang, Yungen Xu, Mallikarjun Reddy Ravi